SARS-CoV-2 –specific B- and T-cell immunity in a population-based study of young Swedish adults
Young adults are now considered major spreaders of coronavirus disease 2019 (COVID-19) disease. Although most young individuals experience mild to moderate disease, there are concerns of long-term adverse health effects. The impact of COVID-19 disease and to which extent population-level immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exists in young adults remain unclear.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Sophia Bj örkander, Likun Du, Fanglei Zuo, Sandra Ekström, Yating Wang, Hui Wan, Natalia Sherina, Lisanne Schoutens, Juni Andréll, Niklas Andersson, Antonios Georgelis, Anna Bergström, Harold Marcotte, Inger Kull, Lennart Hammarström, Erik Melén, Qi Source Type: research
More News: Allergy | Allergy & Immunology | Coronavirus | COVID-19 | Respiratory Medicine | SARS | Study | Sweden Health